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As the health care needs of populations change in 
low- and middle-income countries, the demand for afford-
able, accurate, and timely diagnostic testing will increase 
substantially. The need for such testing is threefold: (1) 
to guide treatment of patients, (2) to improve standards 
of practice in health care systems, and (3) to monitor the 
health of populations through accurate data collection 
and analysis. To inform public policy decision making, 
increased access to quality pathology laboratory diagnoses 
will require a broader and more holistic approach than has 
been attempted in the past. This will include addressing 
workforce development, quality and practice standards, 
education and training, laboratory infrastructure, resourc-
ing, and advocacy for services.
Changing Needs for Health Care Services
As many nations undergo sustained economic growth, 
improvements in health care systems and delivery of ser-
vices, increased population, and increased longevity, the 
focus of health care is shifting from a recent emphasis on 
infectious diseases such as human immunodeficiency virus 
(HIV), tuberculosis (TB), and malaria to include noncommu-
nicable diseases (NCDs) such as cancer and cardiovascular 
diseases.1 As governments and other development partners 
continue to implement the Millennium Development Goals, 
addressing the impact of NCDs on the health of populations 
will grow in importance.2,3 In addition, populations within 
these nations are beginning to expect improved access to 
routine health care for all age groups, including care for dis-
eases and conditions that, until recently, have received little 
attention. Increased urbanization in many areas, combined 
with increased personal income, raises exposure to risk fac-
tors for many chronic diseases, which will further drive the 
need for improved access to quality health care.
In addition to the growing demand for access to health 
care in general, there is a growing demand for improved 
laboratory and pathology diagnostic services, including 
better clinical laboratory tests, appropriate point-of-care 
tests, tests for cancer screening, and surgical pathology and 
cytopathology services, which are especially important for 
cancer care. As patients have increasing access to modern 
treatments, particularly in cancer care and other NCDs, so 
will they need access to the most up-do-date laboratory 
diagnostic tests to allow for personalized health care. Thus, 
for example, in cancer care, a first and specific goal should 
be that no patient be treated for cancer without a pathologic 
diagnosis. Although limited to certain areas, available data 
indicate that we are far from reaching this goal. In one study 
during 1994-1996 in Uganda, only 64.5% of patients in an 
HIV cohort and 68.9% of cancer registry patients had a tis-
sue diagnosis.4 A subsequent study by the same authors, the 
Kampala Cancer Registry Report for 2007-2009, showed 
a tissue diagnosis rate of only 58.6%.5 A subsequent goal, 
one that depends on meeting the first goal, is that all 
patients with cancer receive appropriate clinical and patho-
logic tumor staging prior to therapy. As these goals are met, 
patient care will improve, and the data collected will sup-
port multidisciplinary tumor boards, cancer registries, and 
accuracy in death certification. As the quality and amount of 
data collected increase, both allocation of health resources 
and public policy can be improved.6 In the long term, the 
use of quality diagnostics, particularly accurate pathologic 
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diagnosis, helps create the foundation for developing and 
implementing population-specific research efforts.
Many countries, however, still are unable to provide 
this type of access to their populations. The problem is par-
ticularly evident in sub-Saharan Africa. The World Health 
Organization’s (WHO’s) 2006 World Health Report empha-
sizes the disparity between population and access to health 
care providers: although this region bears more than 24% of 
the global burden of disease, it has only 3% of the world’s 
health care workers and less than 1% of the world’s financial 
resources.7 For the 847,000,000 persons living in sub-Saha-
ran Africa, there are only 1.1 doctors and nurses per 1,000 
population.8 This is in stark contrast to the United States and 
United Kingdom, where there are 12.3 and 12.7 doctors and 
nurses per 1,000 population, respectively.8 Access to pathol-
ogists in sub-Saharan Africa is even more limited: several 
countries have no pathologists, and the ratio of pathologists 
to population is less than 10% of that in the United States 
and United Kingdom.9 By one estimate, at current rates of 
training in sub-Saharan Africa, it will take more than 500 
years for the number of pathologists per 1,000 population to 
reach the levels that currently exist in the United States and 
United Kingdom (K. Fleming, personal communication).
In addition to the issue of access to pathology and labora-
tory services, the issue of quality of these services remains of 
grave concern. Although there are sites in sub-Saharan Africa 
where regulation and resources yield services of high quality, 
this is not true in most areas. In perhaps the best-studied area, 
again Kampala, Uganda, the variability of quality in clinical 
laboratories is striking. In this study of clinical laboratories, 
the investigators identified and surveyed 954 laboratories, 
of which only 45 (5%) “met or surpassed the lowest qual-
ity standards defined by the WHO/AFRO-derived laboratory 
strengthening tool.”10 Despite efforts through the President’s 
Emergency Plan for AIDS Relief (PEPFAR) and other pro-
grams, which have resulted in important progress in improv-
ing laboratory quality and rates of accreditation, major gaps 
remain throughout sub-Saharan Africa.11
The emphasis on the development and use of rapid 
pathology diagnostic tests for treating patients with HIV/
AIDS, TB, and malaria—through programs such as PEP-
FAR and the Global Fund—was successful and appropriate 
because of the way those diagnostic and treatment programs 
were designed and implemented. That approach, however, is 
not practicable for addressing the many noncommunicable 
and other diseases and conditions of public health impor-
tance throughout the world. The multiplicity of NCDs such 
as cancer, as well as the many types and complexity of tests 
needed for contemporary cancer diagnosis and treatment, 
precludes simple rapid diagnostic testing at this time. Even 
with emerging technologies, it is unlikely that affordable, 
high-quality rapid diagnostic tests can be made available on a 
global basis in the near future. It is, however, possible to pro-
vide accurate and cost-effective pathology diagnostic testing 
for many NCDs by simply improving and extending existing 
laboratory services to populations that currently lack access to 
them. But it is clear that no single approach can be expected 
to be successful in all areas. What is lacking is the evidence 
to guide policy makers to make informed decisions as to how 
to improve laboratory and diagnostic services, and therefore 
health care, on a country-by-country basis.
Pathology Matters: Advocating for 
Improved Diagnostic Services
In the past, pathologists and other laboratory profession-
als have been unable to provide accurate and timely diagnoses 
due to a lack of resources and insufficient contact with (and 
encouragement from) clinicians. As a result, the clinicians, 
facing high numbers of patients with acute infectious diseases, 
trauma, childbirth, and other urgent or emergent conditions, 
have learned to practice medicine with limited, often poor-
quality laboratory diagnostic services. This contrasts with 
services that are readily available and the standard of best prac-
tice in high-income countries. In many regions, poor-quality 
services have created a degree of professional cynicism among 
clinicians and providers. For all these reasons, clinicians have 
not advocated for improved laboratory diagnostic testing, nor 
have patients and the public demanded it. Outside of the recent 
emphasis on treating HIV/AIDS, TB, and malaria guided by 
quality diagnostic testing, little or no emphasis has been placed 
on pathology testing as a critical component of health care.
As governments, clinicians, and patients begin to move 
toward improved health care for larger patient populations, 
it is clear that the current state of diagnostic testing must 
change dramatically. There is a clear need for advocacy: 
to encourage governments, ministries of health, and their 
development partners to allocate much-needed resources for 
pathology and for clinicians to advocate with the govern-
ment and hospital and clinic administrators to resource and 
improve access to diagnostic testing. There is also a need for 
advocacy to increase pathology education and training pro-
grams to provide adequate numbers of pathologists and other 
laboratory professionals. Importantly, patients should advo-
cate for access to quality pathology laboratory diagnostic 
services within the context of their right to good health care.
The Road Ahead
Providing access to quality pathology services on the 
scale needed will not be an easy or inexpensive undertaking. 
In addition to the need for effective advocacy, major gaps 
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exist in infrastructure, laboratory quality assurance and test-
ing standards, education and training, and workforce devel-
opment. There is a lack of coordination of efforts within and 
between countries in many regions. Leveraging resources 
and efforts between organizations and programs remains 
an elusive concept due to a multiplicity of funding streams, 
divergent interests, nonalignment of goals, and a historic 
unwillingness or inability of many governments to provide 
oversight and leadership.
Perhaps the biggest obstacle to date has been the absence 
of a vision and a plan for making necessary changes. That has 
now changed. At a meeting held in Siena, Italy, in June 2014, 
a diverse group of stakeholders, consisting of experts in histo-
pathology, cytopathology, microbiology, laboratory manage-
ment, public health advocacy, funding, and process improve-
ment, met to define a vision for increasing and improving 
pathology diagnostic services in sub-Saharan Africa.
The outcome of the meeting was optimistic but also 
sobering. There is optimism because of a clear consensus 
that the lack of quality and accessible pathology diagnostic 
services is an issue that is not insurmountable and can be 
resolved using current technology. It was sobering because 
of the scale of the issue, the urgent need to develop large-
scale and sustainable funding mechanisms, and the need 
for longer-term efforts to ensure that any improvements are 
capable of being replicated.
Ultimately, the African Strategies for Advancing 
Pathology (ASAP) Group envisions a future in which the 
importance of pathology in sub-Saharan Africa is recognized 
at local, national, regional, continental, and international 
levels, with a competent pathology workforce and a number 
of expert centers and networks that are supported by a high-
quality sustainable delivery system to improve the quality of 
life of persons living in sub-Saharan Africa.
The ASAP Group has generated a high-level strategic 
plan that delineates strategies to improve the framework for 
pathology in sub-Saharan Africa, including:
• Create and implement an advocacy strategy for 
pathology.
• Generate an economic case for pathology.
• Raise the pathology profile in the medical community.
• Build networks for teaching and training.
• Define and develop standards for acceptable 
practices.
• Build, strengthen, and maintain operational 
laboratories.
• Leverage private, research, and commercial sectors 
for pathology.
The goal of the Siena meeting was to create a vision, 
strategy, and structure. The way forward will be long 
and difficult. It should not be underestimated. But as one 
historian wrote about seemingly insurmountable matters, 
“Whatever the new challenges and problems, constructive 
individuals with a combination of insight and enterprise 
[are] entirely capable of coping with them.”13 The ASAP 
Group has come together to provide a framework for such 
individuals to take up the challenge.
Key Messages
• Global need for access to high-quality health care 
is increasing; the increase is driven by social, 
economic, and demographic factors.
• High-quality health care is not possible without 
the availability of accurate and timely diagnosis of 
diseases and conditions.
• Direct patient care, epidemiology, resource 
allocation, and public health policy also require 
more accurate and timely diagnosis of diseases and 
conditions.
• Because major gaps in the availability of pathology 
and laboratory services exist in many regions, and 
current efforts to improved access to these services 
are insufficient, new strategies to increase capacity 
are needed.
• The ASAP Group has provided the framework 
of such a new strategy and will be working with 
committed individuals and partners to deliver them.
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